Brind.

Eli Lilly and AstraZeneca are involved in drug development and market competition, with the FDA issuing approvals and legal actions involving both companies.

1 report, 1 independent Updated Tue 00:00

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Eli Lilly and Company AstraZeneca FDA

Keep exploring

The entities involved

Eli Lilly and Company
American pharmaceutical company
- Acquisition of ImClone Systems provided an oncology franchise.14:57
- Eli Lilly and Novo Nordisk developed GLP-1 weight-loss drugs, coinciding with operational status changes at SSA offices in New York.12:14
AstraZeneca
British-Swedish pharmaceutical company
- AstraZeneca is investing in its US footprint to reach revenue goals and addressing a center opening on LinkedIn.16:52
- AstraZeneca and Tarsus Pharmaceuticals, Inc. are two healthcare companies that are currently competing for investment.Tue 11:59
FDA
- MJFF supports Oncodesign Precision Medicine's drug development program, while the EMA supports its toxicology strategy.17:58
- CVS Health's Caremark profit depends on drug payment gaps, while GRAIL awaits FDA approval until 2027, and Jim Cramer called CVS Health cheap.15:50

Coverage

Newest first; wire copies grouped

Tue 00:00biopharmadive.com